135
Participants
Start Date
March 31, 2002
Primary Completion Date
August 31, 2004
Imatinib
Novartis Investigative Site, Ancona
Novartis Investigative Site, Aviano
Novartis Investigative Site, Bari
Novartis Investigative Site, Bergamo
Novartis Investigative Site, Bologna
Novartis Investigative Site, Candiolo
Novartis Investigative Site, Ferrara
Novartis Investigative Site, Florence
Novartis Investigative Site, Genova
Novartis Investigative Site, Livorno
Novartis Investigative Site, Meldola
Novartis Investigative Site, Messina
Novartis Investigative Site, Milan
Novartis Investigative Site, Monserrato
Novartis Investigative Site, Napoli
Novartis Investigative Site, Nola
Novartis Investigative Site, Padua
Novartis Investigative Site, Palermo
Novartis Investigative Site, Perugia
Novartis Investigative Site, Pisa
Novartis Investigative Site, Ravenna
Novartis Investigative Site, Roma
Novartis Investigative Site, Rozzano
Novartis Investigative Site, Sassari
Novartis Investigative Site, Torino
Novartis Investigative Site, Verona
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY